ly 134046 has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collins, MA; Gearhart, DA; Neafsey, EJ | 1 |
1 other study(ies) available for ly 134046 and Parkinson Disease
| Article | Year |
|---|---|
Phenylethanolamine N-methyltransferase has beta-carboline 2N-methyltransferase activity: hypothetical relevance to Parkinson's disease.
Topics: Adrenal Medulla; Benzazepines; Enzyme Inhibitors; Humans; Methyltransferases; Parkinson Disease; Phenylethanolamine N-Methyltransferase; Substrate Specificity | 2002 |